US 8323617
Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
granted A61KA61K31/573A61K31/728
Quick answer
US patent 8323617 (Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid) held by ANIKA THERAPEUTICS, INC. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ANIKA THERAPEUTICS, INC.
- Grant date
- Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/573, A61K31/728, A61K31/729, A61K35/28